.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Teva
Express Scripts
Boehringer Ingelheim
Cipla
Dow
UBS
McKinsey
Cerilliant
McKesson

Generated: September 24, 2017

DrugPatentWatch Database Preview

DOFETILIDE Drug Profile

« Back to Dashboard

Which patents cover Dofetilide, and what generic Dofetilide alternatives are available?

Dofetilide is a drug marketed by Mayne Pharma Inc and is included in one NDA.

The generic ingredient in DOFETILIDE is dofetilide. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dofetilide profile page.

Summary for Tradename: DOFETILIDE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list61
Clinical Trials: see list8
Patent Applications: see list1,483
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOFETILIDE at DailyMed

Pharmacology for Tradename: DOFETILIDE

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma Inc
DOFETILIDE
dofetilide
CAPSULE;ORAL207058-001Jun 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma Inc
DOFETILIDE
dofetilide
CAPSULE;ORAL207058-002Jun 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mayne Pharma Inc
DOFETILIDE
dofetilide
CAPSULE;ORAL207058-003Jun 6, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Baxter
Daiichi Sankyo
Dow
AstraZeneca
Fuji
Farmers Insurance
Federal Trade Commission
UBS
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot